Cargando…

Addition of Alanyl-Glutamine to Dialysis Fluid Restores Peritoneal Cellular Stress Responses – A First-In-Man Trial

BACKGROUND: Peritonitis and ultrafiltration failure remain serious complications of chronic peritoneal dialysis (PD). Dysfunctional cellular stress responses aggravate peritoneal injury associated with PD fluid exposure, potentially due to peritoneal glutamine depletion. In this randomized cross-ove...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kratochwill, Klaus, Boehm, Michael, Herzog, Rebecca, Gruber, Katharina, Lichtenauer, Anton Michael, Kuster, Lilian, Csaicsich, Dagmar, Gleiss, Andreas, Alper, Seth L., Aufricht, Christoph, Vychytil, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5074513/ https://www.ncbi.nlm.nih.gov/pubmed/27768727 http://dx.doi.org/10.1371/journal.pone.0165045

Ejemplares similares

Functional and Transcriptomic Characterization of Peritoneal Immune-Modulation by Addition of Alanyl-Glutamine to Dialysis Fluid
por: Herzog, Rebecca, et al.
Publicado: (2017)

Targeted Metabolomic Profiling of Peritoneal Dialysis Effluents Shows Anti-oxidative Capacity of Alanyl-Glutamine
por: Wiesenhofer, Florian M., et al.
Publicado: (2019)

Effects of Alanyl-Glutamine Treatment on the Peritoneal Dialysis Effluent Proteome Reveal Pathomechanism-Associated Molecular Signatures
por: Herzog, Rebecca, et al.
Publicado: (2018)

Peritoneal Dialysis Fluid Supplementation with Alanyl-Glutamine Attenuates Conventional Dialysis Fluid-Mediated Endothelial Cell Injury by Restoring Perturbed Cytoprotective Responses
por: Herzog, Rebecca, et al.
Publicado: (2020)

The Peritoneal Surface Proteome in a Model of Chronic Peritoneal Dialysis Reveals Mechanisms of Membrane Damage and Preservation
por: Boehm, Michael, et al.
Publicado: (2019)

Alanyl-Glutamine Restores Tight Junction Organization after Disruption by a Conventional Peritoneal Dialysis Fluid
por: Bartosova, Maria, et al.
Publicado: (2020)

Vibrational Spectroscopy of Peritoneal Dialysis Effluent for Rapid Assessment of Patient Characteristics
por: Grunert, Tom, et al.
Publicado: (2020)

Assessing mechanical catheter dysfunction in automated tidal peritoneal dialysis using cycler software: a case control, proof-of-concept study
por: Oviedo Flores, Krystell, et al.
Publicado: (2022)

Publisher Correction: Assessing mechanical catheter dysfunction in automated tidal peritoneal dialysis using cycler software: a case control, proof-of-concept study
por: Flores, Krystell Oviedo, et al.
Publicado: (2022)

Cross-Omics Comparison of Stress Responses in Mesothelial Cells Exposed to Heat- versus Filter-Sterilized Peritoneal Dialysis Fluids
por: Kratochwill, Klaus, et al.
Publicado: (2015)

Senescence-Associated Changes in Proteome and O-GlcNAcylation Pattern in Human Peritoneal Mesothelial Cells
por: Herzog, Rebecca, et al.
Publicado: (2015)

Is there such a thing as biocompatible peritoneal dialysis fluid?
por: Schmitt, Claus Peter, et al.
Publicado: (2016)

New‐Onset Diabetes Mellitus in Peritoneal Dialysis and Hemodialysis Patients: Frequency, Risk Factors, and Prognosis—A Review
por: Yarragudi, Rajashri, et al.
Publicado: (2019)

Oral administration of alanyl-glutamine and glutamine improve random pattern dorsal skin flap survival in rats
por: Karimipour, Mojtaba, et al.
Publicado: (2018)

A systems pharmacology workflow with experimental validation to assess the potential of anakinra for treatment of focal and segmental glomerulosclerosis
por: Boehm, Michael, et al.
Publicado: (2019)

In-Depth Analysis of the Extracorporeal Proteome Adsorbed to Dialysis Membranes during Hemodialysis
por: Daniel-Fischer, Lisa, et al.
Publicado: (2022)

Effects of alanyl-glutamine supplementation on the small intestinal mucosa barrier in weaned piglets
por: Xing, Shen, et al.
Publicado: (2017)

Metabolic engineering of Escherichia coli for efficient production of l-alanyl-l-glutamine
por: Zhu, Jiangming, et al.
Publicado: (2020)

Intervention and Mechanisms of Alanyl-glutamine for Inflammation, Nutrition, and Enteropathy: A Randomized Controlled Trial
por: Moore, Sean R., et al.
Publicado: (2020)

Examination of the efficacy of acute L-alanyl-L-glutamine ingestion during hydration stress in endurance exercise
por: Hoffman, Jay R, et al.
Publicado: (2010)

Treatment with Oral Active Vitamin D Is Associated with Decreased Risk of Peritonitis and Improved Survival in Patients on Peritoneal Dialysis
por: Kerschbaum, Julia, et al.
Publicado: (2013)

L-alanyl-L-glutamine ingestion maintains performance during a competitive basketball game
por: Hoffman, Jay R, et al.
Publicado: (2012)

Alanyl-glutamine attenuates 5-fluorouracil-induced intestinal mucositis in apolipoprotein E-deficient mice
por: Araújo, C.V., et al.
Publicado: (2015)

Glutamine and Alanyl-Glutamine Increase RhoA Expression and Reduce Clostridium difficile Toxin-A-Induced Intestinal Epithelial Cell Damage
por: Santos, Ana A. Q. A., et al.
Publicado: (2013)

Supplementation with L-Glutamine and L-Alanyl-L-Glutamine Changes Biochemical Parameters and Jejunum Morphophysiology in Type 1 Diabetic Wistar Rats
por: da Rosa, Carlos Vinicius D., et al.
Publicado: (2015)

Proteome-Wide Differential Effects of Peritoneal Dialysis Fluid Properties in an In Vitro Human Endothelial Cell Model
por: Sacnun, Juan Manuel, et al.
Publicado: (2022)

Antibody Response and Safety After mRNA-1273 SARS-CoV-2 Vaccination in Peritoneal Dialysis Patients – the Vienna Cohort
por: Beilhack, Georg, et al.
Publicado: (2021)

Challenges to dialysis treatment during the COVID-19 pandemic: a qualitative study of patients’ and experts’ perspectives
por: Oviedo Flores, Krystell, et al.
Publicado: (2023)

Alanyl-glutamine protects the intestinal barrier function in trained rats against the impact of acute exhaustive exercise
por: Freitas, A.K.L., et al.
Publicado: (2020)

Parameters associated with therapeutic response using peritoneal dialysis for therapy refractory heart failure and congestive right ventricular dysfunction
por: Pavo, Noemi, et al.
Publicado: (2018)

Humoral Response to mRNA-1273 SARS-CoV-2 Vaccine in Peritoneal Dialysis Patients: Is Boostering After Six Months Adequate?
por: Beilhack, Georg, et al.
Publicado: (2022)

Torque teno viral load reflects immunosuppression in paediatric kidney-transplanted patients—a pilot study
por: Uhl, Phoebe, et al.
Publicado: (2020)

Durable Anti-SARS-CoV-2 Antibody Response after mRNA-1273 Booster in Peritoneal Dialysis Patients during the Omicron Wave
por: Beilhack, Georg, et al.
Publicado: (2023)

Protective Effects Oncorneal Endothelium During Intracameral Irrigation Using N-(2)-l-alanyl-l-Glutamine
por: Jin, Mengyi, et al.
Publicado: (2020)

Efficacy of alanyl glutamine in nutritional support therapy for patients with sepsis: A protocol for systematic review and meta-analysis
por: Su, Xiaolei, et al.
Publicado: (2021)

Dietary Bioactive Peptide Alanyl-Glutamine Attenuates Dextran Sodium Sulfate-Induced Colitis by Modulating Gut Microbiota
por: Xu, Qingbiao, et al.
Publicado: (2021)

Icodextrin does not impact infectious and culture-negative peritonitis rates in peritoneal dialysis patients: a 2-year multicentre, comparative, prospective cohort study
por: Vychytil, Andreas, et al.
Publicado: (2008)

Membrane alanyl aminopeptidase
por: Turner, Anthony J.
Publicado: (2004)

Bioimpedance spectroscopy for fluid status assessment in patients with decompensated liver cirrhosis: Implications for peritoneal dialysis
por: Schwaiger, Elisabeth, et al.
Publicado: (2020)

Transcriptional Patterns in Peritoneal Tissue of Encapsulating Peritoneal Sclerosis, a Complication of Chronic Peritoneal Dialysis
por: Reimold, Fabian R., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_hj2klogk8qqhco6otfuflbvrev